Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Plus Therapeutics Inc (NQ: PSTV )

1.230 -0.020 (-1.60%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,320
Open 1.280
Bid (Size) 1.180 (6)
Ask (Size) 1.230 (81)
Prev. Close 1.250
Today's Range 1.200 - 1.290
52wk Range 1.120 - 10.95
Shares Outstanding 2,879,620
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed lower by close to 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-73.57%
-73.57%
1 Month
-54.95%
-54.95%
3 Month
-41.98%
-41.98%
6 Month
-69.61%
-69.61%
1 Year
-81.45%
-81.45%

More News

Read More
Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Plus Therapeutics Earnings Preview
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Plus Therapeutics: Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Is Cancer Diagnostic Focused Biocept Stock Trading Higher Today?
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers
Via Benzinga
Plus Therapeutics Presents Exciting New Clinical Data At Top Cancer Conference
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Earnings Scheduled For August 14, 2023
Via Benzinga
EXCLUSIVE: Plus Therapeutics Lead Candidate Shows Preliminary Safety, Efficacy In Type Of Brain Cancer
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Plus Therapeutics Releases Early-Cut Data From Cancer Studies For Brain Cancer Settings
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Plus Therapeutics – Precision Radiology Is Proving Highly Effective At Fighting Cancer
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
This Company Is Developing Novel Treatments For Difficult To Treat CNS Cancers
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.